Results 161 to 170 of about 63,993 (197)
Some of the next articles are maybe not open access.
Pharmacogenetics and Pharmacovigilance
Drug Safety, 2009Many different types of drugs are available to treat a wide variety of disorders. Why some patients respond to a particular drug and others do not respond, or why some patients tolerate a drug well and others are intolerant of the same drug, are obviously important clinical issues in medicine.
openaire +2 more sources
Pharmacoepidemiology and Drug Safety, 1997
History and current status of monitoring of adverse drug reactions in Poland is presented. The Centre for Monitoring of Adverse Drug Reactions (ADR) was established in 1971. The number of suspected drug reactions reported varied in subsequent years. In the analysed periods of time 1972-1984 and 1985-1994, 956 and 961 reports were received respectively.
A, Czarnecki, A, Maciejczyk
openaire +2 more sources
History and current status of monitoring of adverse drug reactions in Poland is presented. The Centre for Monitoring of Adverse Drug Reactions (ADR) was established in 1971. The number of suspected drug reactions reported varied in subsequent years. In the analysed periods of time 1972-1984 and 1985-1994, 956 and 961 reports were received respectively.
A, Czarnecki, A, Maciejczyk
openaire +2 more sources
Pharmacovigilance of Biopharmaceuticals
Drug Safety, 2009Biopharmaceuticals are important treatment options for a variety of chronic and sometimes life-threatening diseases. Compared with the traditional small molecule drugs, biopharmaceuticals have specific characteristics, which might also influence their safety profile.
Giezen, Thijs J +2 more
openaire +3 more sources
European pharmacovigilance: an overview of pharmacovigilance inspections
Pharmacoepidemiology and Drug Safety, 2005M C, Koster, A H M, van den Oetelaar
openaire +2 more sources
International Journal of Risk & Safety in Medicine, 2012
I Ralph, Edwards, David, Body
openaire +2 more sources
I Ralph, Edwards, David, Body
openaire +2 more sources
Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources
Drug Safety, 2022Likeng Liang, Na Hong, Tianyong Hao
exaly
Strengthening Pharmacovigilance in Africa: PhArmacoVigilance Africa (PAVIA)
PhArmacoVigilance Africa (PAVIA) is a project that was funded by the European Union under European and Developing Countries Clinical Trials Partnership (EDCTP2) programme (grant number CSA2016S-1627-PAVIA). This was originally planned as a 4-year project to be executed from March 2018 until February 2022 but was granted a 1-year no-cost extension ...Cobelens, Frank G. J., Nderu, Michelle
openaire +1 more source